Other Name
Sponsors Type
Federal/National
Country
United States
Grant Types
Fellowship/Scholarship/Dissertation Internship/Work-study Research Project Training/Course Travel Workshop/Conference Post-doctoral Collaboration/Cooperative Agreement Equipment/Facility/Organization Artistic/Exhibit/Collection Publishing/Editorial Other
Topics
cancer research health disparities translational cancer research cancer prevention cancer biology cancer therapeutics clinical trials health equity data sharing health outcomes
 Contact Info
Phone
(1-800-422-6237)
Email
NCIinfo@nih.gov
Go to Sponsor Website
Last modified on 2025-11-18 01:06:31
Description
The National Cancer Institute (NCI) is the federal government's principal agency for cancer research and training. **NCI Mission** NCI leads, conducts, and supports cancer research across the nation to advance scientific knowledge and help all people live longer, healthier lives.
Sponsor Relationship

  National Cancer Institute is a part of:


  The following sponsors are parts of National Cancer Institute:

Most Recent Grants from This Sponsors
Pancreatic Cancer Detection Consortium: Management and...
Funding Opportunity Number: PAR-28-057 **Background** *Pancreatic Cancer*: Pancreatic...
Added on 2026-09-25
Pancreatic Cancer Detection Consortium: Research Units...
**Funding Opportunity Number: PAR-28-056** **Background** *Pancreatic Cancer*: Pancreatic...
Added on 2026-09-25
Division of Cancer Epidemiology and Genetics (DCEG)...
DCEG is the world's largest cancer epidemiology research group. Our renowned international...
Added on 2026-09-17
NIH Brain Development Cohorts (NBDC) and Population...
Funding Opportunity Number: PAR-27-051 **Background** This Resource Access Program allows...
Added on 2026-09-01
Deadline Approaching Grants
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-25-243 **Purpose** This notice of funding opportunity...
Deadline on 2026-10-05
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy...
Funding Opportunity Number: PAR-25-175 **PURPOSE** The purpose of this initiative is to...
Deadline on 2026-10-05
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-24-311 ****PURPOSE**** Through this Notice of Funding...
Deadline on 2026-10-05
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and...
Funding Opportunity Number: PAR-25-145 **Purpose** The purpose of this Notice of Funding...
Deadline on 2026-10-05